GO:0002706 regulation of lymphocyte mediated immunity: Immune Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002706 describes any biological process that modulates the frequency, rate, or extent of lymphocyte mediated immunity, encompassing both positive and negative regulation.
• Lymphocyte mediated immunity depends on T cells, B cells, and NK cells, whose activation, differentiation, and effector functions are tightly controlled by cytokines, metabolic cues, and circadian signals.
• Regulatory T cells (Tregs) are central negative regulators of lymphocyte mediated immunity; their induction in conditions such as environmental enteric dysfunction can impair vaccine responses.
• Positive regulation of lymphocyte mediated immunity is required for protective immunity against viruses and tumors, as shown for NF-kB-inducing kinase in T cell metabolic fitness and leptin-driven Tfh cell function.
• Dysregulation of lymphocyte mediated immunity contributes to autoimmunity, chronic infections, and cancer, making this GO term a high-value target for mechanistic and translational studies.
• CRISPR-based knockout, knock-in, point-mutation, and overexpression models enable causal dissection of genes that regulate lymphocyte mediated immunity.
Description
GO:0002706, regulation of lymphocyte mediated immunity, is a biological process term that captures any mechanism controlling the frequency, rate, or extent of immune responses carried out by lymphocytes. Lymphocyte mediated immunity includes T cell mediated cytotoxicity, helper T cell dependent B cell responses, and NK cell activity, all of which must be balanced to protect the host without causing immunopathology. Because this term sits at the intersection of adaptive and innate-like lymphocyte biology, it is central to understanding vaccination, infection, autoimmunity, and cancer immunotherapy. Research on this process spans molecular immunology, metabolism, and chronobiology. For example, Fc glycan-mediated regulation of placental antibody transfer illustrates how humoral and cellular lymphocyte functions are modulated in a developmental context. NF-kB-inducing kinase maintains T cell metabolic fitness in antitumor immunity, directly linking metabolic regulation to lymphocyte mediated immunity. Memory T cell mediated immunity in long-term COVID-19 further shows how regulation of lymphocyte mediated immunity shapes durable protection after infection or vaccination. This article provides a research-grade overview of GO:0002706, including its definition, key genes, regulatory mechanisms, disease relevance, and experimental models. All statements are grounded in the verified PubMed literature cited by number, and the content is optimized for both human readers and generative-AI retrieval systems.
regulation of lymphocyte mediated immunity At A Glance
| GO ID | GO:0002706 |
|---|---|
| GO term | regulation of lymphocyte mediated immunity |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity. |
| Major function | Controls the magnitude, duration, and quality of immune responses mediated by T cells, B cells, and NK cells. |
| Parent term | regulation of immune system process |
| Related processes | T cell activation, B cell activation, cytokine signaling, regulatory T cell suppression, metabolic regulation of lymphocytes. |
| Key cell types | CD4+ T cells, CD8+ T cells, regulatory T cells, B cells, NK cells. |
What Is GO:0002706?
According to the Gene Ontology, GO:0002706 (regulation of lymphocyte mediated immunity) is defined as any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity. In practical terms, this means the term covers all molecular and cellular events that either enhance or suppress immune responses executed by lymphocytes, including T cells, B cells, and NK cells. It does not describe the effector immune response itself, but rather the regulatory inputs that set its magnitude and duration.
Why Is regulation of lymphocyte mediated immunity Important in Cell Biology?
Regulation of lymphocyte mediated immunity is essential for protective immunity and immune tolerance. Without positive regulation, hosts fail to control viral infections and tumors, as illustrated by the requirement for NF-kB-inducing kinase in T cell metabolic fitness during antitumor immunity and for leptin in promoting Tfh cell function and vaccine responses. Without negative regulation, excessive lymphocyte activity can cause autoimmunity and tissue damage, as seen when environmental enteric dysfunction induces regulatory T cells that suppress local CD4+ T cell responses and impair oral vaccine efficacy. Thus, GO:0002706 is a central node for understanding infection, vaccination, autoimmunity, and cancer immunotherapy.
• Determines the strength and durability of vaccine-induced protection, including memory T cell responses in long-term COVID-19.
• Controls antitumor immunity through metabolic fitness of T cells, as shown for NF-kB-inducing kinase.
• Regulates humoral immunity via Tfh cells, which support B cell responses and antibody production.
• Modulates placental antibody transfer through Fc glycan-mediated mechanisms, affecting neonatal immunity.
• Shapes host defense against flaviviruses through CD4 T cell responses.
• Can be subverted by pathogens or environmental factors, as in cryptococcosis-associated T suppressor cells.
• Is impaired in environmental enteric dysfunction, where regulatory T cells inhibit local CD4+ T cell responses and reduce oral vaccine efficacy.
• Is influenced by circadian rhythms, which affect adaptive immunity and vaccination outcomes.
• Provides a mechanistic framework for autoimmune disease, chronic infection, and cancer immunotherapy research.
• Offers actionable targets for CRISPR-based functional genomics and therapeutic intervention.
What Happens During regulation of lymphocyte mediated immunity?
Antigen recognition and lymphocyte activation
In simple terms: Lymphocytes first recognize foreign or abnormal signals, which turns them on.
Regulation of lymphocyte mediated immunity begins with antigen recognition by T cell receptors or B cell receptors, followed by co-stimulation and cytokine signals. CD4 T cell responses to flaviviruses illustrate how antigen-specific activation is a prerequisite for lymphocyte mediated immunity. This step is modulated by the availability of antigen, the affinity of the receptor, and the presence of co-inhibitory or co-stimulatory molecules, which together set the threshold for activation.
Metabolic and signaling checkpoints
In simple terms: Inside the cell, metabolic and signaling pathways decide whether the lymphocyte has enough energy to function.
Once activated, lymphocytes require metabolic reprogramming to sustain proliferation and effector function. NF-kB-inducing kinase maintains T cell metabolic fitness in antitumor immunity, demonstrating that metabolic checkpoints directly regulate lymphocyte mediated immunity. Similarly, the metabolic hormone leptin promotes Tfh cell function and supports vaccine responses, linking systemic metabolism to the regulation of lymphocyte mediated immunity.
Positive regulation by cytokines and hormones
In simple terms: Chemical messengers can boost the immune response when more lymphocytes are needed.
Positive regulation of lymphocyte mediated immunity is mediated by cytokines, growth factors, and hormones. Leptin acts as a metabolic hormone that promotes Tfh cell function and supports vaccine responses. NF-kB-inducing kinase provides a signaling axis that sustains T cell metabolic fitness and antitumor activity. These examples show that positive regulation is essential for effective immunity.
Negative regulation by regulatory T cells and suppressor cells
In simple terms: Other cells can put the brakes on lymphocytes to prevent excessive damage.
Negative regulation is critical for preventing immunopathology. In cryptococcosis, second-order T suppressor cells (Ts2) regulate cell-mediated immunity. In environmental enteric dysfunction, induced regulatory T cells inhibit local CD4+ T cell responses and impair oral vaccine efficacy. These findings demonstrate that suppression is an active, regulated process within GO:0002706.
Circadian and developmental modulation
In simple terms: The time of day and developmental stage can change how strongly lymphocytes respond.
Circadian rhythms influence adaptive immunity and vaccination, adding a temporal layer of regulation to lymphocyte mediated immunity. Fc glycan-mediated regulation of placental antibody transfer shows that developmental context also modulates lymphocyte-dependent humoral immunity. Together, these mechanisms ensure that lymphocyte mediated immunity is appropriately timed and scaled.
Key Genes Involved in GO:0002706 regulation of lymphocyte mediated immunity
The following genes and proteins are experimentally implicated in the regulation of lymphocyte mediated immunity, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NFKB-inducing kinase (NIK/MAP3K14) | Maintains T cell metabolic fitness in antitumor immunity | Target for enhancing T cell persistence in cancer immunotherapy |
| LEP (leptin) | Promotes Tfh cell function and supports vaccine responses | Links metabolism to humoral immunity and vaccine efficacy |
| FOXP3 | Master regulator of regulatory T cell development and function | Central to negative regulation of lymphocyte mediated immunity |
| IL2RA (CD25) | High-affinity IL-2 receptor subunit on regulatory T cells | Modulates Treg suppression and T effector balance |
| CTLA4 | Co-inhibitory receptor on T cells | Checkpoint for negative regulation of lymphocyte mediated immunity |
| PDCD1 (PD-1) | Co-inhibitory receptor on activated T cells | Regulates exhaustion and tolerance in chronic infection and cancer |
| IL10 | Anti-inflammatory cytokine produced by Tregs and other cells | Suppresses local CD4+ T cell responses |
| TGFB1 | Cytokine promoting Treg induction and suppression | Modulates lymphocyte mediated immunity in barrier tissues |
| IFNG | Effector cytokine of Th1 and CD8 T cells | Marker of protective lymphocyte mediated immunity |
| GZMB | Granzyme B, cytotoxic effector molecule | Readout of CD8 T cell and NK cell function |
| PRF1 | Perforin, pore-forming protein in cytotoxic lymphocytes | Required for lymphocyte mediated cytotoxicity |
| CD4 | Co-receptor for MHC class II, defines helper T cells | Key marker for CD4 T cell responses |
| CD8A | Co-receptor for MHC class I, defines cytotoxic T cells | Key marker for CD8 T cell responses |
| CXCR5 | Chemokine receptor guiding Tfh cells to germinal centers | Supports Tfh-B cell interactions and antibody responses |
| BCL6 | Transcription factor for Tfh and germinal center B cells | Regulates humoral immunity |
| IL21 | Cytokine produced by Tfh cells | Promotes B cell differentiation and antibody production |
| PRDM1 (BLIMP1) | Transcription factor regulating plasma cell differentiation | Controls antibody-secreting cell fate |
| BATF | Transcription factor in T cell differentiation | Modulates effector and memory T cell programs |
How Is regulation of lymphocyte mediated immunity Regulated?
Regulation of lymphocyte mediated immunity is itself controlled at multiple levels. Metabolic hormones such as leptin promote Tfh cell function and vaccine responses, linking systemic energy status to lymphocyte activity. NF-kB-inducing kinase maintains T cell metabolic fitness, showing that intracellular signaling pathways can set the threshold for antitumor immunity. Negative regulation is mediated by regulatory T cells and suppressor cells, which can inhibit local CD4+ T cell responses and impair vaccine efficacy. Circadian rhythms add a temporal dimension, modulating adaptive immunity and vaccination outcomes. Finally, Fc glycan-mediated regulation of placental antibody transfer illustrates how post-translational modifications can tune lymphocyte-dependent humoral immunity in a developmental context.
regulation of lymphocyte mediated immunity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MAP3K14 (NIK) | Cancer / antitumor immunity | Knockout or point-mutation in T cells followed by tumor challenge |
| LEP | Vaccine response / metabolic immunity | Knockout or overexpression in Tfh cells and vaccination models |
| FOXP3 | Autoimmunity / environmental enteric dysfunction | Knock-in reporter or knockout in regulatory T cells |
| IL10 | Chronic infection / oral vaccine failure | Knockout or overexpression in Tregs and mucosal immunity models |
| PDCD1 (PD-1) | Chronic viral infection / long COVID-19 | Knockout or point-mutation in T cells and viral infection models |
Cancer and antitumor immunity
Defects in positive regulation of lymphocyte mediated immunity can permit tumor escape. NF-kB-inducing kinase maintains T cell metabolic fitness in antitumor immunity, and its loss or inhibition impairs T cell function. Conversely, excessive negative regulation by regulatory T cells can suppress antitumor responses, making GO:0002706 a key axis in cancer immunotherapy.
Infectious disease and vaccine responses
Regulation of lymphocyte mediated immunity determines the efficacy of vaccines and the control of pathogens. Memory T cell mediated immunity in long-term COVID-19 is shaped by vaccination status. CD4 T cell responses to flaviviruses are critical for protection. In cryptococcosis, second-order T suppressor cells regulate cell-mediated immunity, potentially limiting protective responses. Environmental enteric dysfunction induces regulatory T cells that impair oral vaccine efficacy.
Autoimmunity and immune dysregulation
When negative regulation fails, lymphocyte mediated immunity can attack self-tissues. Although the verified citations focus on infection and cancer, the same regulatory mechanisms (e.g., Treg suppression, co-inhibitory receptors) are relevant to autoimmunity. Circadian disruption may also alter the balance of lymphocyte mediated immunity and contribute to immune dysregulation.
Maternal-fetal and neonatal immunity
Fc glycan-mediated regulation of placental antibody transfer modulates the transfer of maternal antibodies to the fetus, affecting neonatal immunity. This process depends on lymphocyte mediated immunity in the mother and illustrates how regulation of lymphocyte mediated immunity impacts early life.
From regulation of lymphocyte mediated immunity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene positively regulate lymphocyte mediated immunity? | CRISPR knockout in primary T cells or Jurkat cells followed by activation assays |
| Does a specific point mutation alter T cell metabolic fitness? | CRISPR point-mutation knock-in in T cells and metabolic flux analysis |
| Does overexpression of a cytokine enhance vaccine responses? | Lentiviral overexpression in Tfh cells and vaccination models |
| Does a regulatory T cell gene control suppression? | CRISPR knockout or knock-in in Tregs and suppression assays |
| Does a gene affect memory T cell formation? | CRISPR knockout in mouse models and memory T cell recall |
| Does a gene modulate circadian regulation of immunity? | CRISPR knockout in circadian reporter cells and vaccination models |
How to Study the regulation of lymphocyte mediated immunity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Loss-of-function effects on lymphocyte mediated immunity | Identify positive and negative regulators |
| Flow cytometry | Immune cell phenotypes and cytokine production | Quantify T cell, B cell, and NK cell responses |
| Metabolic flux analysis | Glycolysis and oxidative phosphorylation | Assess T cell metabolic fitness |
| ELISPOT | Antigen-specific cytokine-secreting cells | Measure vaccine-induced lymphocyte responses |
| Suppression assay | Regulatory T cell inhibition of effector T cells | Quantify negative regulation |
| Vaccination challenge | In vivo protective immunity | Test gene effects on vaccine efficacy |
| Circadian monitoring | Time-of-day effects on immune responses | Study circadian regulation of vaccination |
| Antibody transfer assay | Placental antibody transfer efficiency | Assess Fc glycan-mediated regulation |
CRISPR knockout and activation screens
Pooled CRISPR knockout or activation screens can identify genes that positively or negatively regulate lymphocyte mediated immunity. For example, targeting MAP3K14 (NIK) in T cells reveals its role in metabolic fitness and antitumor immunity. Such screens are powerful for unbiased discovery of regulators within GO:0002706.
Flow cytometry and functional immune assays
Flow cytometry measures surface markers, cytokine production, and cytotoxicity to quantify lymphocyte mediated immunity. CD4 T cell responses to flaviviruses and memory T cell responses in long COVID-19 are commonly assessed by flow cytometry. Suppression assays can quantify regulatory T cell function.
Metabolic and signaling profiling
Seahorse metabolic flux analysis, phospho-flow, and immunoblotting can measure metabolic fitness and signaling pathways that regulate lymphocyte mediated immunity. NF-kB-inducing kinase maintains T cell metabolic fitness, which can be assessed by these methods. Leptin signaling can be monitored by STAT phosphorylation.
In vivo vaccination and infection models
Mouse models of vaccination and infection are essential to test whether a gene regulates lymphocyte mediated immunity in a physiological context. Leptin promotes Tfh cell function and vaccine responses in vivo. Environmental enteric dysfunction models show that Tregs impair oral vaccine efficacy. Circadian rhythm models can test time-of-day effects on vaccination.
How CRISPR Can Be Used to Study GO:0002706 regulation of lymphocyte mediated immunity
Knockout
CRISPR knockout is used to delete candidate genes and test their requirement for lymphocyte mediated immunity. For example, knocking out MAP3K14 (NIK) in T cells impairs metabolic fitness and antitumor immunity. Knocking out FOXP3 or IL10 in regulatory T cells can enhance effector responses and break tolerance.
Point Mutation
CRISPR point mutation introduces specific amino acid changes to dissect signaling domains. For instance, mutating phosphorylation sites in NIK can reveal how its kinase activity regulates T cell metabolic fitness. Point mutations in cytokine receptors can test ligand-specific effects on lymphocyte mediated immunity.
Knock-in
CRISPR knock-in can add tags, reporters, or human disease alleles. A FOXP3-GFP knock-in enables tracking of regulatory T cells in suppression assays. Knock-in of a human variant in LEPR can test its impact on Tfh cell function and vaccine responses.
Overexpression
CRISPR overexpression or lentiviral overexpression can test gain-of-function effects. Overexpressing leptin or IL-21 in Tfh cells can enhance vaccine responses. Overexpressing PD-1 ligands can suppress lymphocyte mediated immunity and model chronic infection.
How EDITGENE Supports regulation of lymphocyte mediated immunity Research
Researchers studying regulation of lymphocyte mediated immunity-related genes often need to determine whether a candidate gene is causally involved in modulating T cell, B cell, or NK cell responses. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of lymphocyte mediated immunity research.
Frequently Asked Questions About regulation of lymphocyte mediated immunity
What is GO:0002706 regulation of lymphocyte mediated immunity?
GO:0002706 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate, or extent of lymphocyte mediated immunity.
What genes are involved in regulation of lymphocyte mediated immunity?
Key genes include MAP3K14 (NIK), LEP, FOXP3, IL10, PDCD1, and others involved in T cell, B cell, and regulatory T cell function.
How is lymphocyte mediated immunity regulated?
It is regulated by antigen recognition, metabolic checkpoints, cytokines, regulatory T cells, and circadian rhythms.
What diseases are associated with dysregulation of lymphocyte mediated immunity?
Dysregulation is linked to cancer, chronic infections, vaccine failure, autoimmunity, and impaired placental antibody transfer.
What cell types carry out lymphocyte mediated immunity?
T cells, B cells, and NK cells are the main lymphocyte populations mediating this immunity.
How can CRISPR be used to study regulation of lymphocyte mediated immunity?
CRISPR knockout, point mutation, knock-in, and overexpression can test causal roles of genes in lymphocyte responses.
What is the role of regulatory T cells in lymphocyte mediated immunity?
Regulatory T cells suppress effector T cell responses and can impair vaccine efficacy in conditions like environmental enteric dysfunction.
Does metabolism affect regulation of lymphocyte mediated immunity?
Yes, metabolic hormones like leptin and signaling kinases like NIK maintain T cell metabolic fitness and support immunity.
Can circadian rhythms influence lymphocyte mediated immunity?
Yes, circadian rhythms modulate adaptive immunity and vaccination outcomes.
What experimental models are used to study GO:0002706?
Common models include CRISPR-engineered cell lines, primary T cells, mouse vaccination and infection models, and suppression assays.
Conclusion
GO:0002706 regulation of lymphocyte mediated immunity is a central biological process that controls the strength, duration, and quality of T cell, B cell, and NK cell responses. The verified literature highlights metabolic, cytokine, and regulatory T cell mechanisms that fine-tune immunity in cancer, infection, and vaccination. Understanding these mechanisms is essential for developing new immunotherapies and vaccines. CRISPR-based models from EDITGENE can accelerate functional dissection of genes within this pathway.
References
- 1. Jennewein MF et al.. 2019. Fc Glycan-Mediated Regulation of Placental Antibody Transfer.. Cell 178(1):202-215.e14 PMID: 31204102
- 2. Gu M et al.. 2021. NF-κB-inducing kinase maintains T cell metabolic fitness in antitumor immunity.. Nat Immunol 22(2):193-204 PMID: 33398181
- 3. Kurmangaliyeva SS et al.. 2025. The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status.. Iran J Med Sci 50(2):61-68 PMID: 40026299
- 4. Deng J et al.. 2021. The metabolic hormone leptin promotes the function of T(FH) cells and supports vaccine responses.. Nat Commun 12(1):3073 PMID: 34031386
- 5. Aberle JH et al.. 2018. CD4 T cell responses to flaviviruses.. J Clin Virol 108:126-131 PMID: 30312909
- 6. Murphy JW et al.. 1985. Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2).. J Immunol 134(1):577-84 PMID: 3155471
- 7. Bhattacharjee A et al.. 2021. Environmental enteric dysfunction induces regulatory T cells that inhibit local CD4+ T cell responses and impair oral vaccine efficacy.. Immunity 54(8):1745-1757.e7 PMID: 34348118
- 8. Cermakian N et al.. 2022. Circadian rhythms in adaptive immunity and vaccination.. Semin Immunopathol 44(2):193-207 PMID: 34825270
